Amber Morgan

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Amber Morgan is an author at University of Cambridge specializing in neurodegenerative diseases, parkinson’s disease treatment, and neurotoxic action.

ORCID

Publications per year

2022–2022

Publications

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial

Johannes Levin, Nand Sing, Sue Melbourne et al. · EBioMedicine · 2022 · 85 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

1–1 of 1